- 
                        States Consider Dozens of Bills to Protect 340B Drug Price Subsidy Abuse
                        31 Oct 2025 12:17 GMT
                        
                           … hospitals purchase discounted prescription drugs from manufacturers by  …  per dose. Hospital systems can distribute the drugs at  …  disclosure requirements for 340B drug sales, says Sholty.
                           … provide more transparency.
                          Drug makers whose drugs are listed in …
                         
- 
                        Which blood pressure medication was recalled by Teva Pharmaceuticals over cancer concerns? CHECK OUT Serial numbers HERE
                        31 Oct 2025 12:07 GMT
                         …  recall of its blood pressure medication over worries that the capsules …  compound. The medication';s 1, 2, and 5 mg doses were recalled …  and reduce blood pressure. The drug is sometimes called Minipress, reports … 
- 
                        US pediatrician group recommends against routine use of drug for autism
                        31 Oct 2025 12:23 GMT
                        
                           …  officials touted the decades-old drug in a White House press …  causes and treatments.
                          The generic drug, originally developed by GSK, is …  the process of approving the drug for people with a rare … . We don’t know what dose to start with,” she said …
                         
- 
                        Calluna Pharma Announces U.S. FDA Orphan Drug Designation Granted to CAL101 for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
                        31 Oct 2025 12:49 GMT
                        
                           … the U.S. Food and Drug Administration (FDA) for CAL101 … pulmonary fibrosis (IPF).
                          “Orphan drug designation speaks to the importance … 
                          The FDA grants Orphan Drug Designation to support the  …  to placebo, across all dose levels. Preclinical studies have shown …
                         
- 
                        Viking Therapeutics Stock Powers Toward Best Month Of The Year — Wall Street, Retail Bulls Fired Up On Obesity Drug Promise
                        31 Oct 2025 11:42 GMT
                        
                           …  from Viking’s obesity drug VK2735, fueling further optimism … competition from Viking’s obesity drug VK2735, fueling further optimism … market.
                          Viking’s Obesity Drug Program
                          Viking is developing … early 2026. A maintenance dosing study is currently underway  …
                         
- 
                        Canadians can wait years to get drugs regulators have already deemed safe. Why?
                        31 Oct 2025 11:25 GMT
                        
                           …  oncology drugs usually move through the system more swiftly than medications for … .
                          Johnson & Johnson makes tailored doses of Carvykti for individuals with …  new drugs to public drug plans.
                          After Health Canada approval, new medications go …
                         
- 
                        What’s changing in cancer drug discovery – and why it matters now
                        31 Oct 2025 11:12 GMT
                        
                           …  clinical outcomes.
                          Today, oncology drug discovery has evolved from empirical … enable real-time measurement of drug distribution, target engagement and pharmacodynamic … data, these insights are improving dose selection, resistance prediction and adaptive …
                         
- 
                        FDA: Once Again A Blood Pressure Medication Recall For Cancer Concerns
                        31 Oct 2025 11:05 GMT
                         …  have spanned different blood pressure medications from different manufacturers and different …  includes capsules of three different doses: 1, 2 and 5 mg … , then check whether the medication’s National Drug Code (NDC) and the … 
- 
                        Adagene Announces First Patient Dosed in Randomized Dose Optimization Cohort of the Phase 2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer
                        31 Oct 2025 11:00 GMT
                        
                           …  profile allows for higher dosing and potentially better efficacy, … with the US Food and Drug Administration (FDA):
                          Patient  … Q6W dosing compared to a 20mg/kg loading dose followed … including Fc empowered antibodies, antibody-drug conjugates, and bi/ …
                         
- 
                        FDA Recalls Blood Pressure Drugs Tainted With Cancer-Causing Chemical Contamination In 580,000 Bottles
                        31 Oct 2025 10:44 GMT
                         … based Teva Pharmaceuticals USA and drug distributor Amerisource Health Services  …  subjected to a low dose of nitrosamines in food  … imply that all blood pressure medications are not safe. The … or any strange symptoms during medication use. When these symptoms  …